Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Bowel Cancer Awareness Month starts today!

Bowel Cancer Australia < 1 min read

Bowel Cancer Australia’s signature event to raise awareness of Australia’s second deadliest cancer and funds for the leading community-funded charity dedicated to prevention, early diagnosis, research, quality treatment and care, so everyone affected by bowel cancer can live their best life.

 

  • 1-in-15 Australians will be diagnosed with bowel cancer in their lifetime
  • 15,610 people are diagnosed with bowel cancer each year (300 a week)
  • Bowel cancer claims the lives of 5,354 people every year (103 a week)
  • 1-in-10 new bowel cancer cases diagnosed in people under age 50 (1,680 a year)
  • Almost 99% of bowel cancer cases can be successfully treated, when detected early

 

bowelcanceraustralia.org

Helpline: 1800 727 336 (SCREEN)


Contact details:


For an interview with a medical expert or patient contact:
Stephanie Bansemer-Brown – Bowel Cancer Australia
[email protected]   |   0412 915 797

Media

More from this category

  • Medical Health Aged Care
  • 12/04/2026
  • 07:10
Energy Enhancement System

Court Rules Against Jason Shurka in EESystem Case; $54,034 in Federal Sanctions Ordered

Clark County judge finds defendant’s public statements were not made in good faith. The ruling caps months of legal proceedings brought by the inventor…

  • Contains:
  • Medical Health Aged Care
  • 12/04/2026
  • 06:25
Royal Australian College of GPs

Cleanbill report shows bulk billing rises where funding is strongest, not where competition is greatest

The Royal Australian College of General Practitioners (RACGP) says new Cleanbill data indicates what GPs have consistently warned is true: bulk billing increases where funding better reflects the true cost of care, not where there is greater competition between practices. The Cleanbill report, released today, breaks down bulk billing and gap fees by how rural a practice is based on Modified Monash Model (MM1–7) classification. It shows that the largest increases in 100% bulk billing have occurred in regional and rural areas where government incentives are highest, yet where health department data show there are fewer GPs per person. RACGP…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 10/04/2026
  • 11:12
Aravax

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifyingimmunotherapies for food allergy, today announces two additions to its Board of Directors, former CEO of ALK-Abello A/S, Carsten Hellmann and former Chief Commercial Officer of Aimmune Therapeutics, Andrew Oxtoby. Collectively, Carsten and Andrew bring to Aravax exceptionally deep experience from the pharmaceutical industry and, specifically, the allergy therapeutics field. Andrew has deep pharmaceutical industry expertise spanning development, product launch, fundraising and exits from working with large and small companies in the U.S. and Europe. As Chief Commercial Officer he built the global commercial organisation for the approval and launch in the US…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.